Cargando…
Revolutionising hepatocellular carcinoma surveillance: Harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence prediction: Erratum
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615532/ https://www.ncbi.nlm.nih.gov/pubmed/37904485 http://dx.doi.org/10.1097/MD.0000000000035894 |
| _version_ | 1785129242668826624 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10615532 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106155322023-10-31 Revolutionising hepatocellular carcinoma surveillance: Harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence prediction: Erratum Medicine (Baltimore) Erratum Lippincott Williams & Wilkins 2023-10-27 /pmc/articles/PMC10615532/ /pubmed/37904485 http://dx.doi.org/10.1097/MD.0000000000035894 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. |
| spellingShingle | Erratum Revolutionising hepatocellular carcinoma surveillance: Harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence prediction: Erratum |
| title | Revolutionising hepatocellular carcinoma surveillance: Harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence prediction: Erratum |
| title_full | Revolutionising hepatocellular carcinoma surveillance: Harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence prediction: Erratum |
| title_fullStr | Revolutionising hepatocellular carcinoma surveillance: Harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence prediction: Erratum |
| title_full_unstemmed | Revolutionising hepatocellular carcinoma surveillance: Harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence prediction: Erratum |
| title_short | Revolutionising hepatocellular carcinoma surveillance: Harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence prediction: Erratum |
| title_sort | revolutionising hepatocellular carcinoma surveillance: harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence prediction: erratum |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615532/ https://www.ncbi.nlm.nih.gov/pubmed/37904485 http://dx.doi.org/10.1097/MD.0000000000035894 |